Evaxion A/S (EVAX) stock
EVAXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 20-F on Mar 5, 2026Score 2/30
$2.77+0.03 (+1.09%)
Close on Nov 16, 2026Market cap $23.10MP/E –Yield –
Evaxion A/S EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
No ev/ebitda figures for Evaxion A/S
Evaxion A/S has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?